On Oct. 31, Biogen Idec
- Revenues exceeded analysts' estimates; however, EPS missed by a wide margin.
- Avonex and Rituxan were the major growth drivers.
- Improved operating margins led to a significant rise in net income.
- See Brian Lawler's report on Biogen's quarter.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Avg. Est. |
Q3 2006 |
Q3 2005 |
Change |
|
|---|---|---|---|---|
|
Sales |
$681 |
$703.5 |
$596.2 |
18.0% |
|
Net Profit |
-- |
$156.6 |
$27.2 |
476.1% |
|
EPS |
$0.49 |
$0.45 |
$0.08 |
462.5% |
|
Diluted Shares |
-- |
344.8 |
340.9 |
1.1% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q3 2006 |
Q3 2005 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
90.51% |
84.98% |
5.53 |
|
Operating Margin |
28.05% |
3.55% |
24.50 |
|
Net Margin |
22.26% |
4.56% |
17.70 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets | Q3 2006 | Q3 2005 | Change |
|---|---|---|---|
Cash + ST Invest. | $661.0 | $611.4 | 8.1% |
Accounts Rec. | $282.5 | $403.1 | (29.9%) |
Inventory | $155.1 | $227.5 | (31.8%) |
Liabilities | Q3 2006 | Q3 2005 | Change |
|---|---|---|---|
Accounts Payable | No Data | $48.2 | No Data |
Long-Term Debt | No Data | $42.9 | No Data |
Learn the ways of the balance sheet.
Cash Flow Highlights
Not provided in the press release. (Lame.)
Find out why Fools always follow the money.
Related Companies:
- Sereno
(NYSE:SRA) - Celgene
(NASDAQ:CELG) - Genzyme
(NASDAQ:GENZ)
Related Foolishness:
Biogen Idec is a Motley Fool Stock Advisor recommendation. Check out Tom and David Gardner's market-beating newsletter service, and we'll send you afree report on the Fool's top two picks and the market's dirtiest secret.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so checkFool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
